H5N1 Vaccine Study in Japanese Elderly Population Aged 65 Years and Older

NCT01774032 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

91

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: H5N1 Influenza Vaccine (Whole Virion, Vero Cell-Derived, Inactivated), non-adjuvanted formulation

Sponsor

Alachua Government Services, Inc.